Enhanced differentiation of breast lesions through integration of microvascular flow imaging and machine learning algorithms - Scorecard - MDSpire

Enhanced differentiation of breast lesions through integration of microvascular flow imaging and machine learning algorithms

  • By

  • Fangfang Zhou

  • Wanling Lin

  • Jiqin Yao

  • Xiaoxi Lu

  • Lifang Yu

  • June 17, 2026

  • 0 min

Share

Clinical Scorecard: Improved Differentiation of Breast Lesions Using Microvascular Flow Imaging Combined with Machine Learning Techniques

At a Glance

CategoryDetail
Condition
Key MechanismsMicrovascular Flow Imaging (MV-Flow) enhances visualization of tumor microvasculature, improving diagnostic accuracy and patient outcomes.
Target Population
Care Setting

Key Highlights

  • highlight_2

Guideline-Based Recommendations

Diagnosis

    Management

    • Integrate machine learning models, such as K-Nearest Neighbors and others, with MV-Flow parameters for enhanced diagnostic accuracy.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        MV-Flow provides objective assessment tools for clinical decision support, but clinicians should be aware of its limitations in certain cases.

        Clinical Best Practices

        • practice_2

        Related Resources & Content

        Original Source(s)

        Enhanced differentiation of breast lesions through integration of microvascular flow imaging and machine learning algorithms

        • by Fangfang Zhou, Wanling Lin, Jiqin Yao, Xiaoxi Lu, Lifang Yu

        • June 17, 2026

        Related Content

        Correction: MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma

        Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia

        Expert consensus from the Chinese medical association on pharmaceutical management of combined cardio-oncology physician-pharmacist clinics